Karen Reckamp

25PUBLICATIONS
170CO-AUTHORS
Molecular targetsPredictive and prognostic markersAutonomic nervous systemMedical genetics (excl. cancer genetics)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jun 03, 2026
Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators.

|Feb 27, 2026
Circulating Inflammatory and Mitochondrial Biomarkers Associated with Cachexia in Advanced Non-Small Cell Lung Cancer.

Kamya Sankar, Elham Kazemian, Nicole Lorona

|Dec 22, 2025
CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (NRG1) Fusions.

Tejas Patil, Jessica J Lin, Parneet K Cheema

|Sep 24, 2025
Benchmarking the Current Landscape: Insights From an Association of American Cancer Institutes Survey on Academic Cancer Service Lines.

Paula M Fracasso, Nicole L Simone, Stephanie J Si Lim

|Jun 04, 2025
Elevated ctDNA Tumor Fraction Is Associated with Improved Mutation Detection but Worse Overall Survival in Advanced Non-Small Cell Lung Cancer: A Lung-MAP Study.

Philip C Mack, Mary W Redman, Hanna Tukachinsky

|May 15, 2025
An evaluation of patritumab deruxtecan for the treatment of EGFR-mutated non-small cell lung cancer.

Barliz Waissengrin, Karen L Reckamp

Pageof 5

Frequent Collaborators

5 joint publications

Mary W Redman

4 joint publications

Hossein Borghaei

4 joint publications

David R Gandara

4 joint publications

David E Kozono